1,3-dimethyl-2-oxabicyclo[2.1.1]hexan-4-amine hydrochloride
Structure Info
- Chemspace ID
- CSCS00116209952 (Synthesis)
- CAS
- 2248268-09-7
- MFCD
- MFCD31718761
- IUPAC Name
- 1,3-dimethyl-2-oxabicyclo[2.1.1]hexan-4-amine hydrochloride
- Mol formula
- C7H14ClNO
- Mol weight
- 164 Da
- Catalog Number(s)
- BB4LS-EN300-6497234, BD01554451, BL62806, CS-0134120, CSC116209952, EN300-6497234, Y3133992, YPD26809, ZXC290651
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -0.16
- Heavy atoms count
- 10
- Rotatable bond count
- 0
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 1
- Polar surface area (Å)
- 35
- Hydrogen bond acceptors count
- 2
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSCS00116209952
Items Overall 10 items from 4 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 50 mg | 712.00 | |
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 100 mg | 925.00 | |
Description: Name:1,3-Dimethyl-2-oxabicyclo[2.1.1]hexan-4-amine hydrochloride; CAS: 2248268-09-7 | ||||||
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 50 mg | 712.00 | |
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 100 mg | 925.00 | |
Description: Name:1,3-Dimethyl-2-oxabicyclo[2.1.1]hexan-4-amine hydrochloride; CAS: 2248268-09-7 | ||||||
| eNovation CN | 40 days | China To: | 95 | 50 mg | 1,104.00 | |
| eNovation CN | 40 days | China To: | 95 | 100 mg | 1,426.00 | |
| eNovation CN | 40 days | China To: | 95 | 250 mg | 2,001.00 | |
| eNovation CN | 40 days | China To: | 95 | 500 mg | 3,116.50 | |
| eNovation CN | 40 days | China To: | 95 | 1 g | 3,979.00 | |
Description: 1,3-dimethyl-2-oxabicyclo[2.1.1]hexan-4-aminehydrochloride; CAS: 2248268-09-7 | ||||||
| Zerenex Molecular Ltd | TBD | United Kingdom To: | 95 | 1 g | POA | |
Description: CAS: 2248268-09-7 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire